Drug makers Cipla and Glenmark are recalling products from the American market due to manufacturing issues, according to the ...

Appearing as if he is trailing along behind an asthma patient, Walter the Dino awkwardly fits into elevators and doctors’ ...

Objectives Continuous albuterol nebulization is generally administered at 2.5–20 mg/hr at most centers. We examined the effect of high-dose (75 or 150 mg/hr) albuterol on clinical variables in ...

Albuterol 90mcg/inh; metered-dose aerosol. <4yrs: not recommended. ≥4yrs: 2 inh every 4–6 hrs as needed; 1 inh every 4 hrs may suffice. Exercise–induced bronchospasm: 2 inh 15 minutes before ...

Albuterol (as sulfate) 0.083%; soln for inh. Avoid excessive use. Sensitivity to sympathomimetics. Discontinue if paradoxical bronchospasm or cardiovascular effects occur. Cardiovascular disease ...

Cipla said the albuterol sulfate inhalation aerosol is a generic therapeutic equivalent of an inhaler produced by Merck and Company. N EW DELHI: Indian drug maker Cipla’s US unit on Friday ...

The Senate Finance Committee introduced bipartisan legislation Friday aimed at preventing and reducing generic drug shortages by leveraging Medicare and Medicaid programs. The draft legislation ...

An albuterol/budesonide fixed-dose combination rescue medication has been shown to reduce severe exacerbations in patients with asthma for the first time, according to positive Phase 3 trial ...

The EMS crew was about to administer epinephrine, “only they hadn’t noticed what I had; the patient’s heart rate was 268” ...

Her health had been fairly good before last winter, though, even at age 64, health care was not something she prioritized.

“We’ve actually seen a spike in albuterol toxicity,” said Takeuchi. “Albuterol is the inhaler that people use when they have ...

Increment in HR vs initial % 12.6 ± 10.8 Increment in HR from hospital discharge, % 87.9 ± 32.1 Decrement in DBP vs initial, % 43.9 ± 15.2 Decrement in DBP vs hospital discharge, % 53.5 ± 12.0 ...